Where are we now and where are we going?
作者信息
Karlan B Y
出版信息
Gynecol Oncol. 1995 Dec;59(3):315-7.
PMID:8522246
Abstract
摘要
相似文献
1
Where are we now and where are we going?我们现在身处何方，又将去往何处？
Gynecol Oncol. 1995 Dec;59(3):315-7.
2
Mechanism-based therapy for leukemia: a lesson from ATRA therapy.
Nagoya J Med Sci. 2001 Nov;64(3-4):103-8.
3
[Advances in medical genetics].[医学遗传学进展]
Zhonghua Yi Xue Za Zhi. 1993 Dec;73(12):748-9.
4
Introduction to molecular oncology.分子肿瘤学导论
Anat Pathol. 1997;2:227-38.
5
Differentiation therapy in acute promyelocytic leukemia: European experience.急性早幼粒细胞白血病的分化治疗：欧洲经验
J Cell Physiol. 1997 Nov;173(2):285-7. doi: 10.1002/(SICI)1097-4652(199711)173:2<285::AID-JCP37>3.0.CO;2-C.
6
Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).全反式维甲酸诱导缓解治疗急性早幼粒细胞白血病期间止血分子标志物的长期随访。庆应义塾大学血液肿瘤协作研究组（KHOCS）。
Thromb Haemost. 1997 Apr;77(4):641-5.
7
Acute promyelocytic leukemia: biology and treatment.
Semin Oncol. 1997 Feb;24(1):92-102.
8
Tretinoin in the treatment of acute promyelocytic leukemia.维甲酸治疗急性早幼粒细胞白血病。
Cancer Pract. 1996 Jul-Aug;4(4):220-3.
9
[Arsenic and retinoic acid, towards targeted treatments of acute promyelocytic leukemia?].[砷与维甲酸，走向急性早幼粒细胞白血病的靶向治疗？]
Bull Acad Natl Med. 1998;182(1):63-71.
10
[Development of gynecologic oncology in the USA].
Gynakologe. 1986 Jun;19(2):60-1.
Zotero 插件